Gateway Wealth Partners, LLC Pfizer Inc Transaction History

Gateway Wealth Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 16, 2024	SELL	$25.26 - $29.6 $47,387 - $55,529	-1,876 Reduced 20.72%	7,176 $201 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $12,919 - $14,835	-499 Reduced 5.22%	9,052 $251 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $274,574 - $356,641	-10,508 Reduced 52.39%	9,551 $275 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $33,534 - $39,197	-1,045 Reduced 4.95%	20,059 $665 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $35,361 - $40,912	979 Added 4.86%	21,104 $774 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $76,259 - $99,278	1,936 Added 10.64%	20,125 $821 Million
Q4 2022 Feb 15, 2023	BUY	$41.75 - $54.5 $759,390 - $991,300	18,189 New	18,189 $932 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Gateway Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Gateway Wealth Partners, LLC with notifications on news.